PTCT Form 144: 3,019 Shares Registered for Sale

PTCT filed a Form 144 reporting the proposed sale of 3,019 shares of common stock that vested on 02/15/2026.

Rhea-AI Filing Summary

PTCT filed a Form 144 reporting the proposed sale of 3,019 shares of common stock that vested on 02/15/2026. The filing lists the shares as arising from Restricted Stock Vesting and identifies Fidelity Brokerage Services LLC in the securities section. The excerpt also lists multiple recent sales by Mark Boulding between 01/05/2026 and 02/18/2026, including transactions of 2,266, 1,739, and 4,879 shares on specific dates with corresponding proceeds shown.

Insights

Corporate Governance Analyst

Rule 144 notice records a proposed resale tied to vested restricted stock and lists recent insider sales.

The filing shows 3,019 common shares identified as resulting from Restricted Stock Vesting on 02/15/2026. The seller is listed in the securities section alongside Fidelity Brokerage Services LLC.

Separately, multiple sales by Mark Boulding between 01/05/2026 and 02/18/2026 are recorded with dollar proceeds (for example $171,190.18 for 2,266 shares on 01/05/2026). The filing is administrative: transaction timing and methods beyond the listed dates are not specified in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PTCT's Form 144 report?

The Form 144 reports the proposed sale of 3,019 common shares that vested on 02/15/2026. It states the shares arose from Restricted Stock Vesting and lists recent sales by an insider in January–February 2026.

Who is shown selling shares in the filing for PTCT?

The excerpt lists multiple sales by Mark Boulding between 01/05/2026 and 02/18/2026. Example transactions include 2,266 shares on 01/05/2026 for $171,190.18 and 4,879 shares on 01/07/2026.

Are the 3,019 shares being sold by the issuer or a selling stockholder?

The filing identifies the securities to be sold as tied to Restricted Stock Vesting on 02/15/2026, with the entry listing the issuer/compensation provenance. The excerpt does not detail post-vesting sale mechanics.

Does the filing show proceeds for recent insider sales?

Yes. The excerpt lists dollar proceeds for several transactions; for example, 2,266 shares on 01/05/2026 show proceeds of $171,190.18 and 4,879 shares on 01/07/2026 show $377,839.55. The filing lists these as past sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 09:56 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001578852
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PTC THERAPEUTICS, INC.
SEC File Number	001-35969
Address of Issuer	500 WARREN CORPORATE CENTER DRIVE WARREN NEW JERSEY 07059
Phone	9082227000
Name of Person for Whose Account the Securities are To Be Sold	Boulding Mark Elliott
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3019	207012.83	80288305	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	Restricted Stock Vesting	Issuer			3019	02/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/05/2026	2266	171190.18
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/06/2026	1739	133811.88
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/07/2026	4879	377839.55
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/08/2026	4033	308761.28
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/09/2026	2314	180314.42
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	02/17/2026	2813	194906.02
Mark Boulding 500 Warren Corporate Center Drive Warren NJ 07059	Common	02/18/2026	3081	213687.69

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/04/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark Boulding
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)